Effects of Chinese Liquors on Cardiovascular Disease Risk Factors in Healthy Young Humans

Table 3

Fasting concentrations of cardiovascular disease risk factors before and after the intervention in female subjects.

Variables	TFL-female (𝑛=11)			TCL-female (𝑛=11)			𝑃 value
	Day 0	Day 28	Difference; (95% CIs)	Day 0	Day 28	Difference; (95% CIs)	Time	Liquor	Time × Liquor
Body weight (kg)	53.96±6.08	53.41±6.09	−0.55; (−1.61, 0.52)	53±7.57	52.73±7.15	−0.27; (−1.23, 0.68)	0.217	0.778	0.676
HDL (mmol/L)	1.43±0.15	1.59±0.15	0.16; (0.09, 0.24)^**	1.48±0.40	1.61±0.46	0.12; (0, 0.24)^*	<0.001	0.504	0.817
LDL-C (mmol/L)	2.11±0.58	2.18±0.59	0.07; (−0.04, 0.19)	2.16±0.38	2.11±0.31	−0.05; (−0.34, 0.23)	0.892	0.93	0.939
TC (mmol/L)	4.16±0.62	4.14±0.58	−0.02; (−0.21, 0.17)	4.34±0.64	4.12±0.68	−0.22; (−0.60, 0.16)	0.225	0.732	0.309
HDL-C/LDL-C	0.74±0.29	0.79±0.29	0.05; (0.01, 0.09)^*	0.69±0.17	0.75±0.15	0.06; (−0.01, 0.13)	0.005	0.669	0.814
TC/HDL-C	2.91±0.35	2.60±0.29	−0.32; (−0.41, −0.22)^**	3.05±0.64	2.68±0.50	−0.37; (−0.53, −0.22)^**	<0.001	0.554	0.501
TG (mmol/L)	0.79±0.18	0.64±0.14	−0.14; (−0.23, −0.05)^**	0.92±0.41	0.78±0.34	−0.14; (−0.30, 0.02)	0.003	0.265	0.97
Apo A1 (g/L)	1.42±0.15	1.61±0.15	0.20; (0.10, 0.29)^**	1.50±0.33	1.65±0.35	0.15; (0.02, 0.27)^*	<0.001	0.592	0.491
Apo B (g/L)	0.48±0.10	0.50±0.11	0.02; (−0.01, 0.05)	0.50±0.06	0.49±0.04	−0.01; (−0.06, 0.04)	0.575	0.889	0.24
Apo B/A1	0.34±0.07	0.31±0.05	−0.03; (−0.05, −0.01)^**	0.35±0.08	0.31±0.07	−0.03; (−0.06, −0.01)^*	0.001	0.939	0.806
DBP (mmHg)	62.18±6.37	67.91±5.28	5.73; (2.06, 9.40)^*	65.82±4.31	65.27±5.90	−0.55; (−3.42, 2.33)	0.022	0.815	0.007
SBP (mmHg)	100.73±7.59	100.64±9.17	−0.09; (−6.26, 6.08)	103.18±4.36	97.91±10.63	−5.27; (−12.14, 1.59)	0.21	0.962	0.225
Glucose (mmol/L)	4.96±0.48	4.60±0.36	−0.36; (−0.60, −0.12)^**	4.95±0.27	4.45±0.53	−0.50; (−0.76, −0.23)^**	<0.001	0.634	0.415
Insulin (μIU/mL)	5.15±1.62	6.00±2.06	0.84; (−0.84, 2.52)	4.22±1.51	4.74±1.90	0.52; (−0.77, 1.82)	0.168	0.081	0.741
HOMA	1.16±0.50	1.24±0.45	0.08; (−0.34, 0.49)	0.94±0.37	0.96±0.47	0.03; (−0.28, 0.33)	0.667	0.123	0.829
Uric acid (μmol/L)	273.25±64.80	252.12±48.61	−21.13; (−41.15, −1.10)^*	278.39±50.53	254±38.99	−24.39; (−65.10, 16.32)	0.037	0.859	0.874
Hs-CRP (mg/L)	0.57±0.41	0.71±0.58	0.14; (−0.06, 0.34)	0.55±0.73	0.57±0.15	0.02; (−0.41, 0.45)	0.117	0.109	0.145

TFL: tea-flavor liquor; TCL: traditional Chinese liquor; TG: triacylglycerol; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; ApoA1: apolipoprotein A1; ApoB: apolipoprotein B; DBP: diastolic blood pressure; SBP: systolic blood pressure; HOMA: Homeostasis Model Assessment. ^∗𝑃<0.05, compared to day 0 for each intervention; ^∗∗𝑃<0.01, compared to day 0 for each intervention.